Evidence map›Paper›PMID 34663629›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2021

Amyloidogenic Processing of Amyloid Precursor Protein Drives Stretch-Induced Disruption of Axonal Transport in hiPSC-Derived Neurons.

Rodrigo S Chaves, My Tran, Andrew R Holder, Alexandra M Balcer, Andrea M Dickey, Elizabeth A Roberts, Brian G Bober, Edgar Gutierrez, Brian P Head, Alex Groisman and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. The Amyloid Precursor Protein Regulates Synaptic Transmission at Medial Perforant Path Synapses.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2023
    Article
  8. Article
  9. Review
  10. Review
  11. Unraveling axonal mechanisms of traumatic brain injury.Acta neuropathologica communications · 2022
    Article
  12. Review
  13. Article
  14. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Rodrigo S ChavesDepartment of Cellular and Molecular Medicine, University of California, San Diego, California 92093.
My TranSanford Consortium for Regenerative Medicine, La Jolla, California 92037.
Andrew R HolderSanford Consortium for Regenerative Medicine, La Jolla, California 92037.
Alexandra M BalcerSanford Consortium for Regenerative Medicine, La Jolla, California 92037.
Andrea M DickeyDepartment of Cellular and Molecular Medicine, University of California, San Diego, California 92093.ORCID 0000-0001-8725-0982
Elizabeth A RobertsDepartment of Cellular and Molecular Medicine, University of California, San Diego, California 92093.
Brian G BoberDepartment of Bioengineering, University of California, San Diego, California 92093.
Edgar GutierrezDepartment of Physics, University of California, San Diego, California 92093.
Brian P HeadResearch Division, VA San Diego Healthcare System, San Diego, California 92161.
Alex GroismanDepartment of Physics, University of California, San Diego, California 92093.
Lawrence S B GoldsteinDepartment of Cellular and Molecular Medicine, University of California, San Diego, California 92093.ORCID 0000-0003-0636-9186
Angels Almenar-QueraltDepartment of Cellular and Molecular Medicine, University of California, San Diego, California 92093 sbshah@health.ucsd.edu aalmenar@health.ucsd.edu.
Sameer B ShahDepartment of Bioengineering, University of California, San Diego, California 92093 sbshah@health.ucsd.edu aalmenar@health.ucsd.edu.
University of California San Diego · USSanford Consortium for Regenerative Medicine · USUC San Diego Health System · USUniversity of California System · US

Funding

VIRUS-INDUCED BRAIN PATHOLOGYP50AG005131 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BREWER, JAMES B · 1985 to 2018
$55.4M
Elucidating AD genotype-phenotype relationships using genetics of human IPS cellsRF1AG048083 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GOLDSTEIN, LAWRENCE S. · 2014 to 2014
$1.9M
BLRD VA I01 BX003671NIA NIH HHS P50 AG005131NIA NIH HHS RF1 AG048083
6 · The paper itself

Abstract

Traumatic brain injury (TBI) results in disrupted brain function following impact from an external force and is a risk factor for sporadic Alzheimer's disease (AD). Although neurologic symptoms triggered by mild traumatic brain injuries (mTBI), the most common form of TBI, typically resolve rapidly, even an isolated mTBI event can increase the risk to develop AD. Aberrant accumulation of amyloid β peptide (Aβ), a cleaved fragment of amyloid precursor protein (APP), is a key pathologic outcome designating the progression of AD following mTBI and has also been linked to impaired axonal transport. However, relationships among mTBI, amyloidogenesis, and axonal transport remain unclear, in part because of the dearth of human models to study the neuronal response following mTBI. Here, we implemented a custom-microfabricated device to deform neurons derived from human-induced pluripotent stem cells, derived from a cognitively unimpaired male individual, to mimic the mild stretch experienced by neurons during mTBI. Although no cell lethality or cytoskeletal disruptions were observed, mild stretch was sufficient to stimulate rapid amyloidogenic processing of APP. This processing led to abrupt cessation of APP axonal transport and progressive formation of aberrant axonal accumulations that contained APP, its processing machinery, and amyloidogenic fragments. Consistent with this sequence of events, stretch-induced defects were abrogated by reducing amyloidogenesis either pharmacologically or genetically. In sum, we have uncovered a novel and manipulable stretch-induced amyloidogenic pathway directly responsible for APP axonal transport dysregulation. Our findings may help to understand and ultimately mitigate the risk of developing AD following mTBI.

Indexed as

Alzheimer DiseaseAmyloid beta-Protein PrecursorAxonal TransportBrain ConcussionCell Culture TechniquesHumansInduced Pluripotent Stem CellsMaleNeuronsAmyloid beta-Protein PrecursorAPP protein, humanAlzheimer's diseaseamyloid beta peptideamyloid precursor proteinaxonal transportbiomechanicsmild traumatic brain injury

Identifiers

PMID34663629
PMCPMC8660048
OpenAlexW3206829838

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.